BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9087989)

  • 1. Meige Syndrome Following COVID Infection.
    Girouard E; Levy A
    Can J Neurol Sci; 2023 Oct; ():1-2. PubMed ID: 37830290
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.
    Ferrazzano G; Muroni A; Conte A; Ercoli T; Tamburini G; Fabbrini G; Berardelli A; Defazio G
    Mov Disord Clin Pract; 2020 Nov; 7(8):950-954. PubMed ID: 33163566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smothering dystonia in a patient with oromandibular dystonia.
    Grill S
    Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability to close eyelids as a feature of palpebral dystonia.
    Krack P; Porschke H; de Decker W; Deuschl G
    Mov Disord; 1997 Mar; 12(2):251-2. PubMed ID: 9087989
    [No Abstract]   [Full Text] [Related]  

  • 7. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
    Jankovic J
    Adv Neurol; 1988; 49():103-16. PubMed ID: 3278535
    [No Abstract]   [Full Text] [Related]  

  • 9. Local side effects of botulinum toxin injections.
    Patrinely JR; Whiting AS; Anderson RL
    Adv Neurol; 1988; 49():493-500. PubMed ID: 3278553
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum A toxin in the treatment of blepharospasm.
    Jankovic J
    Adv Neurol; 1988; 49():467-72. PubMed ID: 3278552
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.